ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE

Suzanne E. Wahrle, Hong Jiang, Maia Parsadanian, Justin Legleiter, Xianlin Han, John D. Fryer, Tomasz Kowalewski, David M. Holtzman

Research output: Contribution to journalArticle

274 Citations (Scopus)

Abstract

ABCA1 is an ATP-binding cassette protein that transports cellular cholesterol and phospholipids onto high density lipoproteine (HDL) in plasma. Lack of ABCA1 in humans and mice causes abnormal lipidation and increased catabolism of HDL, resulting in very low plasma apoA-I, apoA-II, and HDL. Herein, we have used Abca1 -/- mice to ask whether ABCA1 is involved in lipidation of HDL in the central nervous system (CNS). ApoE is the most abundant CNS apolipoprotein and is present in HDL-like lipoproteins in CSF. We found that Abca1 -/- mice have greatly decreased apoE levels in both the cortex (80% reduction) and the CSF (98% reduction). CSF from Abca1 -/- mice had significantly reduced cholesterol as well as small apoE-containing lipoproteins, suggesting abnormal lipidation of apoE. Astrocytes, the primary producer of CNS apoE, were cultured from Abca1 +/+, +/-, and -/- mice, and nascent lipoprotein particles were collected. Abca1 -/- astrocytes secreted lipoprotein particles that had markedly decreased cholesterol and apoE and had smaller apoE-containing particles than particles from Abca1 +/+ astrocytes. These findings demonstrate that ABCA1 plays a critical role in CNS apoE metabolism. Since apoE isoforms and levels strongly influence Alzheimer's disease pathology and risk, these data suggest that ABCA1 may be a novel therapeutic target.

Original languageEnglish (US)
Pages (from-to)40987-40993
Number of pages7
JournalJournal of Biological Chemistry
Volume279
Issue number39
DOIs
StatePublished - Sep 24 2004
Externally publishedYes

Fingerprint

Neurology
Apolipoproteins E
Astrocytes
Central Nervous System
Lipoproteins
Cholesterol
Apolipoprotein A-II
Plasmas
Apolipoproteins
Apolipoprotein A-I
Pathology
Protein Transport
Metabolism
Phospholipids
Carrier Proteins
Alzheimer Disease
Protein Isoforms
Adenosine Triphosphate

ASJC Scopus subject areas

  • Biochemistry

Cite this

ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE. / Wahrle, Suzanne E.; Jiang, Hong; Parsadanian, Maia; Legleiter, Justin; Han, Xianlin; Fryer, John D.; Kowalewski, Tomasz; Holtzman, David M.

In: Journal of Biological Chemistry, Vol. 279, No. 39, 24.09.2004, p. 40987-40993.

Research output: Contribution to journalArticle

Wahrle, SE, Jiang, H, Parsadanian, M, Legleiter, J, Han, X, Fryer, JD, Kowalewski, T & Holtzman, DM 2004, 'ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE', Journal of Biological Chemistry, vol. 279, no. 39, pp. 40987-40993. https://doi.org/10.1074/jbc.M407963200
Wahrle, Suzanne E. ; Jiang, Hong ; Parsadanian, Maia ; Legleiter, Justin ; Han, Xianlin ; Fryer, John D. ; Kowalewski, Tomasz ; Holtzman, David M. / ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 39. pp. 40987-40993.
@article{f4ccb577ecce47dd9c73a16fbd346714,
title = "ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE",
abstract = "ABCA1 is an ATP-binding cassette protein that transports cellular cholesterol and phospholipids onto high density lipoproteine (HDL) in plasma. Lack of ABCA1 in humans and mice causes abnormal lipidation and increased catabolism of HDL, resulting in very low plasma apoA-I, apoA-II, and HDL. Herein, we have used Abca1 -/- mice to ask whether ABCA1 is involved in lipidation of HDL in the central nervous system (CNS). ApoE is the most abundant CNS apolipoprotein and is present in HDL-like lipoproteins in CSF. We found that Abca1 -/- mice have greatly decreased apoE levels in both the cortex (80{\%} reduction) and the CSF (98{\%} reduction). CSF from Abca1 -/- mice had significantly reduced cholesterol as well as small apoE-containing lipoproteins, suggesting abnormal lipidation of apoE. Astrocytes, the primary producer of CNS apoE, were cultured from Abca1 +/+, +/-, and -/- mice, and nascent lipoprotein particles were collected. Abca1 -/- astrocytes secreted lipoprotein particles that had markedly decreased cholesterol and apoE and had smaller apoE-containing particles than particles from Abca1 +/+ astrocytes. These findings demonstrate that ABCA1 plays a critical role in CNS apoE metabolism. Since apoE isoforms and levels strongly influence Alzheimer's disease pathology and risk, these data suggest that ABCA1 may be a novel therapeutic target.",
author = "Wahrle, {Suzanne E.} and Hong Jiang and Maia Parsadanian and Justin Legleiter and Xianlin Han and Fryer, {John D.} and Tomasz Kowalewski and Holtzman, {David M.}",
year = "2004",
month = "9",
day = "24",
doi = "10.1074/jbc.M407963200",
language = "English (US)",
volume = "279",
pages = "40987--40993",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "39",

}

TY - JOUR

T1 - ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE

AU - Wahrle, Suzanne E.

AU - Jiang, Hong

AU - Parsadanian, Maia

AU - Legleiter, Justin

AU - Han, Xianlin

AU - Fryer, John D.

AU - Kowalewski, Tomasz

AU - Holtzman, David M.

PY - 2004/9/24

Y1 - 2004/9/24

N2 - ABCA1 is an ATP-binding cassette protein that transports cellular cholesterol and phospholipids onto high density lipoproteine (HDL) in plasma. Lack of ABCA1 in humans and mice causes abnormal lipidation and increased catabolism of HDL, resulting in very low plasma apoA-I, apoA-II, and HDL. Herein, we have used Abca1 -/- mice to ask whether ABCA1 is involved in lipidation of HDL in the central nervous system (CNS). ApoE is the most abundant CNS apolipoprotein and is present in HDL-like lipoproteins in CSF. We found that Abca1 -/- mice have greatly decreased apoE levels in both the cortex (80% reduction) and the CSF (98% reduction). CSF from Abca1 -/- mice had significantly reduced cholesterol as well as small apoE-containing lipoproteins, suggesting abnormal lipidation of apoE. Astrocytes, the primary producer of CNS apoE, were cultured from Abca1 +/+, +/-, and -/- mice, and nascent lipoprotein particles were collected. Abca1 -/- astrocytes secreted lipoprotein particles that had markedly decreased cholesterol and apoE and had smaller apoE-containing particles than particles from Abca1 +/+ astrocytes. These findings demonstrate that ABCA1 plays a critical role in CNS apoE metabolism. Since apoE isoforms and levels strongly influence Alzheimer's disease pathology and risk, these data suggest that ABCA1 may be a novel therapeutic target.

AB - ABCA1 is an ATP-binding cassette protein that transports cellular cholesterol and phospholipids onto high density lipoproteine (HDL) in plasma. Lack of ABCA1 in humans and mice causes abnormal lipidation and increased catabolism of HDL, resulting in very low plasma apoA-I, apoA-II, and HDL. Herein, we have used Abca1 -/- mice to ask whether ABCA1 is involved in lipidation of HDL in the central nervous system (CNS). ApoE is the most abundant CNS apolipoprotein and is present in HDL-like lipoproteins in CSF. We found that Abca1 -/- mice have greatly decreased apoE levels in both the cortex (80% reduction) and the CSF (98% reduction). CSF from Abca1 -/- mice had significantly reduced cholesterol as well as small apoE-containing lipoproteins, suggesting abnormal lipidation of apoE. Astrocytes, the primary producer of CNS apoE, were cultured from Abca1 +/+, +/-, and -/- mice, and nascent lipoprotein particles were collected. Abca1 -/- astrocytes secreted lipoprotein particles that had markedly decreased cholesterol and apoE and had smaller apoE-containing particles than particles from Abca1 +/+ astrocytes. These findings demonstrate that ABCA1 plays a critical role in CNS apoE metabolism. Since apoE isoforms and levels strongly influence Alzheimer's disease pathology and risk, these data suggest that ABCA1 may be a novel therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=4644361588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644361588&partnerID=8YFLogxK

U2 - 10.1074/jbc.M407963200

DO - 10.1074/jbc.M407963200

M3 - Article

C2 - 15269217

AN - SCOPUS:4644361588

VL - 279

SP - 40987

EP - 40993

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 39

ER -